Herts and Essex Fertility - IVF Spot Purchase NCL ICB

The recent contract award involves the NHS North Central London Integrated Care Board (ICB) as the buying organisation, specifically within the Health Care Services category. The procurement process, titled "Herts and Essex Fertility - IVF Spot Purchase NCL ICB," is part of a Provider Selection Regime under the Health Care Services Regulations 2023. This award decision, completed on 27th June 2025, clarifies a direct contract award without prior competition, focusing on in vitro fertilisation services located in the UKH2 region, specifically aimed at patient choice within fertility treatments.

The contract with the HERTS and ESSEX FERTILITY CENTRE LIMITED was officially signed on 2nd June 2025 and falls under a limited procurement method. Details such as the award address are in Cheshunt, England, and the process bypasses the Public Contracts Regulations 2015. This contract presents significant business opportunities, particularly for healthcare service providers experienced in fertility treatments and services.

Small and medium-sized enterprises (SMEs) in the healthcare industry could potentially benefit from similar future procurement processes by aligning their offerings with the specific needs and preferences of integrated care boards like NHS North Central London ICB. Although the procurement process did not involve a competitive tender stage due to its classified nature, understanding and participating in regulated frameworks could offer growth potential for businesses in the healthcare domain. The directive also illustrates a specialised niche for medical and health service firms, offering them a pathway to embed into patient-driven service allocations under the Provider Selection Regime.